Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $5.85 -0.15 (-2.50%) Closing price 10/3/2025 03:59 PM EasternExtended Trading$5.84 -0.01 (-0.26%) As of 10/3/2025 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Stock Price Performance The Eupraxia Pharmaceuticals (EPRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 120.75%, with a year-to-date return of 84.54%. In the past month, the stock has increased 9.14%, reflecting recent market activity. As of the latest close, Eupraxia Pharmaceuticals traded at $5.85 with a market cap of $210.37 million and volume of 47,972 shares. Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.47%1 Month Performance+9.14%3 Month Performance+7.04%Year-To-Date Performance+84.54%1 Year Performance+120.75% EPRX Stock Chart for Saturday, October, 4, 2025 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$6.00$5.85-2.50%$6.23$5.8247,972 shs$210.37 million10/02/2025$6.07$6.00-1.15%$6.10$5.80111,761 shs$215.76 million10/01/2025$5.90$6.07+2.88%$6.14$5.83144,957 shs$218.28 million09/30/2025$5.77$5.90+2.34%$5.95$5.59132,267 shs$212.16 million09/29/2025$5.74$5.77+0.44%$5.78$5.551.34 million shs$207.31 million09/26/2025$5.76$5.74-0.35%$5.84$5.6058,486 shs$206.41 million09/25/2025$5.59$5.76+3.04%$5.91$5.3990,512 shs$207.14 million09/24/2025$5.66$5.59-1.24%$5.97$5.16419,390 shs$201.02 million09/23/2025$6.65$5.66-14.89%$6.41$5.61981,794 shs$203.53 million09/22/2025$5.96$6.65+11.58%$7.19$5.98330,275 shs$239.14 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$6.04$5.96-1.32%$6.20$5.8237,872 shs$214.33 million09/18/2025$5.38$6.04+12.27%$6.31$5.41184,974 shs$217.20 million09/17/2025$5.33$5.38+0.94%$5.41$5.357,568 shs$193.47 million09/16/2025$5.30$5.33+0.57%$5.35$5.243,518 shs$191.67 million09/15/2025$5.33$5.30-0.56%$5.37$5.224,277 shs$190.59 million09/12/2025$5.47$5.33-2.56%$5.42$5.325,562 shs$191.67 million09/11/2025$5.32$5.47+2.82%$5.55$5.4113,160 shs$196.70 million09/10/2025$5.27$5.32+0.99%$5.38$5.2111,521 shs$191.31 million09/09/2025$5.27$5.27-0.04%$5.32$5.155,481 shs$189.44 million09/08/2025$5.39$5.27-2.23%$5.37$5.226,214 shs$189.51 million09/05/2025$5.36$5.39+0.56%$5.41$5.3030,300 shs$193.82 million09/04/2025$5.40$5.36-0.74%$5.45$5.3020,241 shs$192.75 million09/03/2025$5.41$5.40-0.18%$5.46$5.3735,071 shs$194.18 million Related Companies ProKidney Stock Chart Rezolute Stock Chart Nanobiotix Stock Chart Relay Therapeutics Stock Chart Oculis Stock Chart Iovance Biotherapeutics Stock Chart Niagen Bioscience Stock Chart Septerna Stock Chart Prime Medicine Stock Chart Mind Medicine (MindMed) Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EPRX Stock Alerts